2020 ASCO Virtual Direct™ Highlights


 

2020 ASCO Highlights on Pancreatic Cancer: Perioperative Chemo + mFOLFIRINOX vs. Gemcitabine/nab-Paclitaxel for PDAC - Which Option Improves Chemo Delivery and Early Control of Systemic Disease?

515 views
September 16, 2020
Comments 0
Login to view comments. Click here to Login